Trinity Biotech
TRIB
88 hedge funds and large institutions have $303M invested in Trinity Biotech in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 8 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 28
13% more capital invested
Capital invested by funds: $269M → $303M (+$34.6M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 92 → 88 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
97% less call options, than puts
Call options by funds: $21K | Put options by funds: $637K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$10.5M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$4M |
| 3 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$3.77M |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$3.09M |
| 5 |
AAM
ACK Asset Management
Greenwich,
Connecticut
|
+$2.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$9.71M |
| 2 |
LSC
Lyon Street Capital
Sausalito,
California
|
-$5.58M |
| 3 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$2.19M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.47M |
| 5 |
Renaissance Technologies
New York
|
-$1.44M |
TRIB Hedge Fund Activity: Q1 2015 in Review
88 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2015, worth a combined $303M — up 13% from $269M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of TRIB and 4 opened new positions — a net loss of 4 holders — while 28 trimmed existing stakes and 36 added.
The largest buyer was Boston Partners, adding an estimated $10.5M. The largest seller was Whitebox Advisors, exiting entirely with an estimated $9.71M sold.
- 88 institutional investors held Trinity Biotech (TRIB) as of Q1 2015, down from 92 in Q4 2014.
- Funds reported $303M of Trinity Biotech stock for Q1 2015, up 13% quarter-over-quarter.
- 4 funds opened new Trinity Biotech positions in Q1 2015 and 8 closed out, a net change of -4 holders.
- The largest Trinity Biotech buyer in Q1 2015 was Boston Partners, an estimated $10.5M added.
- The largest Trinity Biotech seller in Q1 2015 was Whitebox Advisors, an estimated $9.71M sold.
Based on aggregated 13F filings for Q1 2015.